Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature

BACKGROUND: Dabigatran is a newly commercialized drug that is replacing other anticoagulants in the prevention of venous thromboembolism, stroke and systemic arterial valve embolism. It acts directly on thrombin presenting in a dynamic and predictable way, which does not require monitoring these pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Corcuera, Marta, Ramírez-Martínez-Acitores, Lucía, López-Pintor, Rosa Mª, Casañas-Gil, Elisabeth, Hernández-Vallejo, Gonzalo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116109/
https://www.ncbi.nlm.nih.gov/pubmed/27694780
http://dx.doi.org/10.4317/medoral.21202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116109/
https://www.ncbi.nlm.nih.gov/pubmed/27694780
http://dx.doi.org/10.4317/medoral.21202

Ejemplares similares